EP Patent

EP2001897A2 — Compounds and methods for treatment of disorders associated with er stress

Assigned to SYNDEXA PHARMACEUTICALS CORP · Expires 2008-12-17 · 17y expired

What this patent protects

The invention provides novel compounds, methods for treating or preventing a condition related to ER-stress, e.g. hypercholesterolemia, atherosclerosis and related conditions, and pharmaceutical compositions related thereto.

USPTO Abstract

The invention provides novel compounds, methods for treating or preventing a condition related to ER-stress, e.g. hypercholesterolemia, atherosclerosis and related conditions, and pharmaceutical compositions related thereto.

Drugs covered by this patent

Patent Metadata

Patent number: EP2001897A2
Jurisdiction: EP
Classification: —
Expires: 2008-12-17
Drug substance claim: No
Drug product claim: No
Assignee: SYNDEXA PHARMACEUTICALS CORP
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.